Home
Issues
Aim & Scope
Open Access
Editorial Board
Indexing
Why publish with us
Contact us
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Special publications & Reprints
Authorship & COI
Principles of Transparency Checklist
Data Policies
Publication Ethics and Publication Malpractice Statement
CONFERENCE PROCEEDING
Problems with defining tobacco products in the Polish anti-tobacco act
1
Department of Commercial Law, University of Gdansk, Gdansk, Poland
2
Department of Public Health and Social Medicine, Medical University of
Gdansk, Gdansk, Poland
Publication date: 2023-04-25
Corresponding author
Tob. Prev. Cessation 2023;9(Supplement):A24
KEYWORDS
ABSTRACT
Introduction:
The Polish Anti-Tobacco Act defines tobacco products as products intended for consumption by consumers, consisting, even partially, of tobacco, including genetically modified tobacco. Such a definition of tobacco products, by referring to tobacco, raises doubts as to the status of new products appearing on the market. Currently, on the basis of the legal solutions in force in Poland, there is a problem with the legal classification of other products containing extracted or synthetic nicotine such as nicotine pouches.
Aim:
The aim of the study was to analyze the legal regulations in force in Poland in terms of qualification of emerging new nicotine-containing products.
Material and Methods:
Dogmatic and legal analysis of the provisions of the Polish Anti-Tobacco Act of 1995 and its amendments and the WHO Framework Convention on Tobacco Control (FCTC).
Results:
Due to the narrow defining of the term "tobacco product" in the Polish anti-tobacco act, there are doubts as to the legal classification of nicotine products newly introduced to the market, which do not contain tobacco itself but only extracted or synthetic nicotine and are not medicinal products at the same time. Although definition of tobacco products corresponds to Art. 1 f. of the FCTC, it seems that it would be consistent with the spirit and objectives of the Convention and the current challenges of public health to extend this concept under the Polish Anti-Tobacco Act to include other nicotine products of a non-medicinal nature.
Conclusions:
In view of the marketing of new forms of administering nicotine, which can be synthetic, it is necessary in the Polish Anti-Tobacco Act to depart from the name "tobacco products" and adopt the name "nicotine products". Only such a broad definition will make it possible to define without any doubt the legal status of new non-medicinal products appearing on the market, without the need to constantly amend the legislation. It should be recognized that such actions are in line with the spirit and objectives of the FCTC.
The Polish Anti-Tobacco Act defines tobacco products as products intended for consumption by consumers, consisting, even partially, of tobacco, including genetically modified tobacco. Such a definition of tobacco products, by referring to tobacco, raises doubts as to the status of new products appearing on the market. Currently, on the basis of the legal solutions in force in Poland, there is a problem with the legal classification of other products containing extracted or synthetic nicotine such as nicotine pouches.
Aim:
The aim of the study was to analyze the legal regulations in force in Poland in terms of qualification of emerging new nicotine-containing products.
Material and Methods:
Dogmatic and legal analysis of the provisions of the Polish Anti-Tobacco Act of 1995 and its amendments and the WHO Framework Convention on Tobacco Control (FCTC).
Results:
Due to the narrow defining of the term "tobacco product" in the Polish anti-tobacco act, there are doubts as to the legal classification of nicotine products newly introduced to the market, which do not contain tobacco itself but only extracted or synthetic nicotine and are not medicinal products at the same time. Although definition of tobacco products corresponds to Art. 1 f. of the FCTC, it seems that it would be consistent with the spirit and objectives of the Convention and the current challenges of public health to extend this concept under the Polish Anti-Tobacco Act to include other nicotine products of a non-medicinal nature.
Conclusions:
In view of the marketing of new forms of administering nicotine, which can be synthetic, it is necessary in the Polish Anti-Tobacco Act to depart from the name "tobacco products" and adopt the name "nicotine products". Only such a broad definition will make it possible to define without any doubt the legal status of new non-medicinal products appearing on the market, without the need to constantly amend the legislation. It should be recognized that such actions are in line with the spirit and objectives of the FCTC.
CONFLICTS OF INTEREST
The authors have no conflicts of interest to declare.
Share
RELATED ARTICLE
| eISSN: | 2459-3087 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
